Atrium Therapeutics, Inc. RNA
—
8.29
0.10
1.22%
as of 25 Sep
- Market cap
- $140.1M
- P/E
- 0.0×
Follow RNA
Growth Flags
show if company had growth for consecutive years
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
264.21 | 267.85 | — | — |
+1 more quarter Free account |
Receivables |
— | 15.00 | — | — | |
Other current assets |
6.33 | 0.14 | 1.31 | — | |
Total current assets |
275.05 | 285.57 | 2.85 | — | |
Property, Plant, Equpment (Net) |
4.07 | 4.34 | 2.72 | — | |
Goodwill and Intangible Assets (Total) |
— | — | — | 0.00 | |
Long-term assets (Other) |
0.11 | 0.42 | — | — | |
Total non-current assets |
5.46 | 6.80 | 5.51 | — | |
Total Assets |
280.51 | 292.36 | 8.35 | 0.00 | |
Accounts Payable |
3.51 | 0.81 | 4.40 | — | |
Accrued Expenses |
17.27 | 9.07 | 12.09 | — | |
Current Part of Capital Lease |
— | — | — | 0.00 | |
Current Part of Taxes to Pay |
— | — | — | 0.00 | |
Current Revenue (Deferred) |
9.04 | 9.34 | 21.64 | — | |
Total current liabilities |
31.51 | 21.91 | 41.80 | — | |
Non-current Revenue (Deferred) |
33.65 | 36.35 | 28.69 | 0.00 | |
Minority Interests |
— | — | — | 0.00 | |
Non-current Liabilities (Other) |
0.78 | — | 0.57 | — | |
Total non-current liabilities |
34.43 | 36.35 | 29.27 | — | |
Total liabilities |
65.94 | 58.26 | 71.07 | 0.00 | |
Additional Paid In Capital |
222.85 | 221.96 | — | 0.00 | |
Preferred Stock (Total) |
— | — | — | 0.00 | |
Common Stock (Net) |
0.02 | 0.02 | — | 0.00 | |
Retained Earnings |
(8.06) | 12.13 | — | — | |
Equity Equivalent |
— | — | (62.71) | — | |
Treasury Stock |
— | — | — | 0.00 | |
Shareholders Equity (Other) |
— | — | — | 0.00 | |
Common Equity (Total) |
214.58 | 234.10 | (62.71) | — | |
Shareholders Equity (Total) |
214.58 | 234.10 | (62.71) | 0.00 | |
Shareholders Equity and Liabilities (Total) |
280.51 | 292.36 | 8.35 | 0.00 | |
Shares (Common) |
17.11 | 17.11 | — | — | |
Shareholders Equity (Tangible) |
214.58 | 234.10 | (62.71) | — | |
Net Debt |
(264.21) | (267.85) | — | — |
In millions of $ except per-share values · columns are period end dates